In comparison, there were 270 cases reporting cardiac defibrillator implant with cardiac catheterization with AMI, HF, or Shock without an MCC with average costs of $43,500 and an average length of stay of 5.7 days in MS-DRG 223, 1,167 cases reporting cardiac defibrillator implant with cardiac catheterization without AMI, HF, or Shock without an MCC with average costs of $42,442 and an average length of stay of 4.6 days in MS-DRG 225, 3,595 cases reporting cardiac defibrillator implant without cardiac catheterization with an MCC with average costs of $53,706 and an average length of stay of 8.3 days in MS-DRG 226, and 2,522 cases reporting cardiac defibrillator implant without cardiac catheterization without an MCC with average costs of $41,636 and an average length of stay of 3.9 days in MS-DRG 227
Uncontrolled trials, like many other Peyronies therapies, have shown some benefit to this treatment, but a recent controlled trial has not shown it to be superior to placebo
[PMC free article: PMC2726827] [PubMed: 19632176] 31
PMID: 36383908
These findings underpin the emerging field of gerobiotics, which explores the role of probiotics and their derivatives in modulating aging processes 14